Claesen, K., Mertens, J. C., Leenaerts, D., & Hendriks, D. (2021). Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery? International Journal of Molecular Sciences, 22(2), 883. https://doi.org/10.3390/ijms22020883
Chicago Style (17th ed.) CitationClaesen, Karen, Joachim C. Mertens, Dorien Leenaerts, and Dirk Hendriks. "Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades After Its Discovery?" International Journal of Molecular Sciences 22, no. 2 (2021): 883. https://doi.org/10.3390/ijms22020883.
MLA (9th ed.) CitationClaesen, Karen, et al. "Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades After Its Discovery?" International Journal of Molecular Sciences, vol. 22, no. 2, 2021, p. 883, https://doi.org/10.3390/ijms22020883.